GSK enters agreement to acquire Nuvalent, Inc. - GSK

As reported by Gsk.com

Acquisition expected to be accretive to sales & core operating profit in 2027 & core EPS in 2029 inclusive of synergies and reprioritisation

▸ MARKET SAMACHAR VIEW

NEUTRAL

Read full article on Gsk.com ↗

Market Samachar is a news aggregator. This article was originally published by Gsk.com. Tap the button above to read the full story on their site.

COMPANIES BlackRock seeks to buy at least $5 billion in SpaceX IPO shares: Report Stocks-Markets-Economic Times
COMPANIES Market Trading Guide: Allied Blenders among 2 stock recommendations for Friday Stocks-Markets-Economic Times
COMPANIES Vedanta demerger: Four spin-off companies list on exchanges on June 15 Stocks-Markets-Economic Times
COMPANIES Goldman Sachs, Morgan Stanley and others buy stake in Rs 1,960 crore Lenskart block deal Stocks-Markets-Economic Times
COMPANIES Block deal: Goldman Sachs picks stake in this smallcap stock that surged 50% in 6 months Stocks-Markets-Economic Times
INDIAN US stocks: Oracle shares tumbles 12% as hefty AI spending, debt plans spook investors Markets-Economic Times
COMPANIES Sebi proposes common price-band mechanism for stocks listed on multiple exchanges Stocks-Markets-Economic Times
INDIAN US stocks | SpaceX IPO draws over $70 billion from retail investors ahead of record stock market debut Markets-Economic Times

GSK enters agreement to acquire Nuvalent, Inc. - GSK

More from Market Samachar